These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37608964)

  • 61. A national audit of radiotherapy in head and neck cancer.
    James ND; Robertson G; Squire CJ; Forbes H; Jones K; Cottier B;
    Clin Oncol (R Coll Radiol); 2003 Apr; 15(2):41-6. PubMed ID: 12708709
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Role of postoperative radiotherapy in resected adenoid cystic carcinoma of the head and neck.
    Choi SH; Yang AJ; Yoon SO; Kim HR; Hong MH; Kim SH; Choi EC; Keum KC; Lee CG
    Radiat Oncol; 2022 Dec; 17(1):197. PubMed ID: 36456955
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
    Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
    JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The utility of postoperative radiotherapy in intermediate-risk oral squamous cell carcinoma.
    Liu T; David M; Batstone M; Clark J; Low TH; Goldstein D; Hope A; Hosni A; Chua B
    Int J Oral Maxillofac Surg; 2021 Feb; 50(2):143-150. PubMed ID: 32616305
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients.
    Alfieri S; Romanò R; Bologna M; Calareso G; Corino V; Mirabile A; Ferri A; Bellanti L; Poli T; Marcantoni A; Grosso E; Tarsitano A; Battaglia S; Blengio F; De Martino I; Valerini S; Vecchio S; Richetti A; Deantonio L; Martucci F; Grammatica A; Ravanelli M; Ibrahim T; Caruso D; Locati LD; Orlandi E; Bossi P; Mainardi L; Licitra LF
    Acta Oncol; 2021 Sep; 60(9):1192-1200. PubMed ID: 34038324
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Delay to surgery after neoadjuvant chemotherapy in head and neck squamous cell carcinoma affects oncologic outcomes.
    Kiong KL; Yao CMKL; Lin FY; Bell D; Ferrarotto R; Weber RS; Lewis CM
    Cancer; 2021 Jun; 127(12):1984-1992. PubMed ID: 33631040
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
    Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
    Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
    Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
    JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
    Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Retrospective analysis of outcome and toxicity after postoperative radiotherapy in patients with squamous cell carcinoma of the lip.
    Lang K; Akbaba S; Held T; El Shafie R; Farnia B; Bougatf N; Bernhardt D; Freudlsperger C; Plinkert PK; Rieken S; Debus J; Adeberg S
    Tumori; 2022 Apr; 108(2):125-133. PubMed ID: 33641520
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The importance of the timing of a gap in radiotherapy of squamous cell carcinomas of the head and neck.
    Herrmann T; Jakubek A; Trott KR
    Strahlenther Onkol; 1994 Sep; 170(9):545-9. PubMed ID: 7940126
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
    Haehl E; Rühle A; David H; Kalckreuth T; Sprave T; Stoian R; Becker C; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Feb; 15(1):31. PubMed ID: 32019576
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review.
    Graboyes EM; Kompelli AR; Neskey DM; Brennan E; Nguyen S; Sterba KR; Warren GW; Hughes-Halbert C; Nussenbaum B; Day TA
    JAMA Otolaryngol Head Neck Surg; 2019 Feb; 145(2):166-177. PubMed ID: 30383146
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of delayed primary treatment initiation on adverse events and recurrence in older head and neck cancer patients.
    Schoonbeek RC; Festen S; van der Laan BFAM; Plaat BEC; Langendijk JA; van Dijk BAC; Halmos GB
    Radiother Oncol; 2022 Aug; 173():154-162. PubMed ID: 35680075
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association between cancer stem cell gene expression signatures and prognosis in head and neck squamous cell carcinoma.
    Kim SI; Woo SR; Noh JK; Lee MK; Lee YC; Lee JW; Kong M; Ko SG; Eun YG
    BMC Cancer; 2022 Oct; 22(1):1077. PubMed ID: 36261806
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database.
    Laramore GE; Scott CB; Schuller DE; Haselow RE; Ervin TJ; Wheeler R; al-Sarraf M; Gahbauer RA; Jacobs JR; Schwade JG
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1011-6. PubMed ID: 8262821
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study.
    Grünwald V; Chirovsky D; Cheung WY; Bertolini F; Ahn MJ; Yang MH; Castro G; Berrocal A; Sjoquist K; Kuyas H; Auclair V; Guillaume X; Joo S; Shah R; Harrington K;
    Oral Oncol; 2020 Mar; 102():104526. PubMed ID: 31978755
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysis.
    Matuschek C; Haussmann J; Bölke E; Gripp S; Schuler PJ; Tamaskovics B; Gerber PA; Djiepmo-Njanang FJ; Kammers K; Plettenberg C; Anooshahr B; Orth K; Budach W
    Radiat Oncol; 2018 Oct; 13(1):195. PubMed ID: 30286777
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Outcome following radiotherapy for head and neck basal cell carcinoma with 'aggressive' features.
    Rishi A; Hui Huang S; O'Sullivan B; Goldstein DP; Lu L; Ringash J; Waldron J; Wells W; Sun A; Hope A; Chung P; Giuliani M; Spreafico A; Tong L; Xu W; Bayley A
    Oral Oncol; 2017 Sep; 72():157-164. PubMed ID: 28797452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.